Angelo Acquafredda
Overview
Explore the profile of Angelo Acquafredda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marucci A, Menzaghi C, Dodesini A, Albizzi M, Acquafredda A, Fini G, et al.
Acta Diabetol
. 2024 Aug;
62(3):323-328.
PMID: 39190183
Aims: Monogenic diabetes is one of the few examples in metabolic diseases in which a real precision medicine approach can be implemented in daily clinical work. Unfortunately, most of what...
2.
Baldassarre M, Loconsole D, Centrone F, Caselli D, Martire B, Quartulli L, et al.
Ital J Pediatr
. 2023 Jun;
49(1):66.
PMID: 37280662
Background: Bronchiolitis is a major cause of hospitalization in infants, particularly in the first six months of life, with approximately 60-80% of admissions due to respiratory syncytial virus (RSV) infection....
3.
Ullmann N, Santamaria F, Allegorico A, Fainardi V, Borrelli M, Ferraro V, et al.
Pediatr Pulmonol
. 2023 Jan;
58(4):1127-1135.
PMID: 36588099
Introduction: There are no recent data on primary ciliary dyskinesia (PCD) distribution, diagnosis and treatment in Italy. Methods: A descriptive study based on a survey questionnaire. It consisted of three...
4.
Faienza M, Brunetti G, Acquafredda A, Delvecchio M, Lonero A, Gaeta A, et al.
Horm Res Paediatr
. 2017 Apr;
87(3):162-169.
PMID: 28391271
Background/aims: Gonadotropin-releasing hormone analogues (GnRHa) represent the gold standard treatment for central precocious puberty (CPP). We aimed to assess the effects of GnRHa treatment on metabolic outcomes, bone status, and...
5.
Faienza M, Acquafredda A, DAniello M, Soldano L, Marzano F, Ventura A, et al.
J Pediatr Endocrinol Metab
. 2013 Apr;
26(7-8):771-4.
PMID: 23612698
We report the case of a boy affected by severe intrauterine and postnatal growth retardation, microcephaly, facial dysmorphisms and postnecrotic cirrhosis, diagnosed at birth as having Seckel syndrome, and subsequently...
6.
Faienza M, Acquafredda A, Tesse R, Luce V, Ventura A, Maggialetti N, et al.
Int J Med Sci
. 2013 Feb;
10(3):338-43.
PMID: 23423872
Background: Increased carotid intima-media thickness (cIMT) is considered a marker of early-onset atherosclerosis and it seems to predict cardiovascular events both in obese and diabetic subjects. We aimed to evaluate...
7.
Urbano F, Acquafredda A, Aceto G, Penza R, Cavallo L
Ital J Pediatr
. 2012 Oct;
38:57.
PMID: 23092196
We report on a case of autoimmune thyroiditis in a 6-month-old patient with cortico-resistant nephrotic syndrome. Normal serum levels of thyroid hormons and thyroid-stimulating hormone were detected with high titers...
8.
Bonifazi E, Acquafredda A, Milano A, Montagna O, Laforgia N
Pediatr Dermatol
. 2010 Jun;
27(2):195-6.
PMID: 20537072
A 27-day-old male infant with diffuse hemangiomatosis of the skin and liver was treated with oral propranolol at a dosage of 2 mg/kg per day. Five months later skin and...
9.
Faienza M, Delvecchio M, Indrio F, Francavilla R, Acquafredda A, Cavallo L
Horm Res
. 2009 Jun;
71(6):372-5.
PMID: 19506396
Craniopharyngioma is a rare, benign, suprasellar brain tumor associated with a significant number of endocrine and metabolic impairments. Growth hormone deficiency, caused by the tumor itself or by its subsequent...
10.
Delvecchio M, Zecchino C, Faienza M, Acquafredda A, Barbetti F, Cavallo L
Diabetes Res Clin Pract
. 2009 Apr;
84(3):332-4.
PMID: 19345438
A girl with celiac disease and KCNJ11 mutation was transferred to glibenclamide when 19.8 years old. When her compliance to the gluten free diet worsened, her metabolic control deteriorated. Since...